BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24417217)

  • 1. A single-center, retrospective analysis evaluating the utilization of the opioid risk tool in opioid-treated cancer patients.
    Ma JD; Horton JM; Hwang M; Atayee RS; Roeland EJ
    J Pain Palliat Care Pharmacother; 2014 Mar; 28(1):4-9. PubMed ID: 24417217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of the opioid risk tool to predict aberrant drug-related behavior in patients receiving opioids for the treatment of chronic pain.
    Witkin LR; Diskina D; Fernandes S; Farrar JT; Ashburn MA
    J Opioid Manag; 2013; 9(3):177-87. PubMed ID: 23771568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study.
    Ives TJ; Chelminski PR; Hammett-Stabler CA; Malone RM; Perhac JS; Potisek NM; Shilliday BB; DeWalt DA; Pignone MP
    BMC Health Serv Res; 2006 Apr; 6():46. PubMed ID: 16595013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient aberrant drug taking behaviors in a large family medicine residency program: a retrospective chart review of screening practices, incidence, and predictors.
    Lewis M; Herndon CM; Chibnall JT
    J Opioid Manag; 2014; 10(3):169-75. PubMed ID: 24944067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective screening with the validated Opioid Risk Tool demonstrates gynecologic oncology patients are at low risk for opioid misuse.
    Garcia C; Lefkowits C; Pelkofski E; Blackhall L; Duska LR
    Gynecol Oncol; 2017 Nov; 147(2):456-459. PubMed ID: 28807366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain.
    Wasan AD; Butler SF; Budman SH; Benoit C; Fernandez K; Jamison RN
    Clin J Pain; 2007 May; 23(4):307-15. PubMed ID: 17449991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic risk factors in the misuse of opioid analgesics.
    Pergolizzi JV; Gharibo C; Passik S; Labhsetwar S; Taylor R; Pergolizzi JS; Müller-Schwefe G
    J Psychosom Res; 2012 Jun; 72(6):443-51. PubMed ID: 22656441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.
    Sehgal N; Manchikanti L; Smith HS
    Pain Physician; 2012 Jul; 15(3 Suppl):ES67-92. PubMed ID: 22786463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of assessment approaches to predict opioid misuse in people with cancer.
    Keall R; Keall P; Kiani C; Luckett T; McNeill R; Lovell M
    Support Care Cancer; 2022 Jul; 30(7):5645-5658. PubMed ID: 35166898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid Misuse Risk: Implementing Screening Protocols in an Ambulatory Oncology Clinic.
    Teulings L; Broglio K
    Clin J Oncol Nurs; 2020 Feb; 24(1):11-14. PubMed ID: 31961849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management.
    Moore TM; Jones T; Browder JH; Daffron S; Passik SD
    Pain Med; 2009 Nov; 10(8):1426-33. PubMed ID: 20021601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model to identify patients at risk for prescription opioid abuse, dependence, and misuse.
    Rice JB; White AG; Birnbaum HG; Schiller M; Brown DA; Roland CL
    Pain Med; 2012 Sep; 13(9):1162-73. PubMed ID: 22845054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of Opioid Risk Tool Among Cancer Patients Receiving Opioid Analgesics.
    Oh SY; Park K; Koh SJ; Kang JH; Chang MH; Lee KH
    J Korean Med Sci; 2022 Jun; 37(23):e185. PubMed ID: 35698838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool.
    Webster LR; Webster RM
    Pain Med; 2005; 6(6):432-42. PubMed ID: 16336480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes Toward Opioids and Risk of Misuse/Abuse in Patients with Chronic Noncancer Pain Receiving Long-term Opioid Therapy.
    Vargas-Schaffer G; Cogan J
    Pain Med; 2018 Feb; 19(2):319-327. PubMed ID: 28340165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avoiding Opioid Misuse After Surgery in the Era of the Opioid Epidemic : Defining the New Normal.
    Petersen MJ; Adams KW; Siparsky NF
    Am Surg; 2020 Nov; 86(11):1565-1572. PubMed ID: 32762470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytic models to identify patients at risk for prescription opioid abuse.
    White AG; Birnbaum HG; Schiller M; Tang J; Katz NP
    Am J Manag Care; 2009 Dec; 15(12):897-906. PubMed ID: 20001171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-assessing the Validity of the Opioid Risk Tool in a Tertiary Academic Pain Management Center Population.
    Clark MR; Hurley RW; Adams MCB
    Pain Med; 2018 Jul; 19(7):1382-1395. PubMed ID: 29408996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription Opioid Misuse Index in sickle cell patients: A brief questionnaire to assess at-risk for opioid abuse.
    Smith WR; McClish DK; Roberts JD; Kandalaft O; Dahman B; Knisely J; Levenson J; Roseff S; Aisiku IP
    J Opioid Manag; 2019; 15(4):323-331. PubMed ID: 31637684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.